Izumchenko and colleagues showed that silencing of tumor suppressor miR-200 could upregulate the expression of negative EGFR regulator of mitogen-inducible gene 6 (MIG6) in the process of transforming growth factor β (TGFβ)-mediated EMT. Here, EGFR is linked to neoplasm.